Pharmacogenetic vs. Concentration-Controlled Optimization of Tacrolimus Dosing in Renal Allograft Recipients

被引：8
|
作者：
Kuypers, D. R. J. [1 ]
机构：
[1] Univ Hosp Leuven, Dept Nephrol & Renal Transplantat, Louvain, Belgium
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 88卷 / 05期
关键词：
D O I：
10.1038/clpt.2010.129
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：595 / 596
页数：2
相关论文
共 50 条
  • [41] Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese lung transplant recipients
    Cai, Xiaojun
    Song, Huizhu
    Jiao, Zheng
    Yang, Hang
    Zhu, Min
    Wang, Chengyu
    Wei, Dong
    Shi, Lingzhi
    Wu, Bo
    Chen, Jingyu
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 152
  • [42] Insulin Resistance in Nonobese Renal Allograft Recipients on Maintenance Doses of Cyclosporine or Tacrolimus
    Soypacaci, Zeki
    Akgun, A. Oguz
    Sengul, Sule
    Keven, Kenan
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (07) : 2339 - 2342
  • [43] Comparison of Viral Immunity in Stable Renal Allograft Recipients Treated with Belatacept or Tacrolimus
    Suessmuth, Y.
    Thompson, P. W.
    Breeden, C.
    Xu, H.
    Johnson, B. E.
    Jones, R. L.
    Stempora, L. A.
    Cheeseman, J.
    Joseph, J.
    Begley, B.
    Thomas, S.
    Kirk, A. D.
    Newell, K.
    Larsen, C. P.
    Mehta, A. K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 40 - 40
  • [44] A Published Pharmacogenetic Algorithm Was Poorly Predictive of Tacrolimus Clearance in An Independent Cohort of Renal Transplant Recipients
    Boughton, O.
    Borgulya, G.
    Cecconi, M.
    MacPhee, I. A. M.
    TRANSPLANTATION, 2012, 94 (10) : 2 - 2
  • [45] Tacrolimus Metabolism Is Different in Recipients of African-American (AA) vs. Non-AA Donor Liver Allograft.
    Malat, G. E.
    Doyle, A.
    Ranganna, K.
    Sass, D.
    Rothstein, K.
    Xiao, G.
    Reich, D.
    Guy, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 265 - 266
  • [46] A published pharmacogenetic algorithm was poorly predictive of tacrolimus clearance in an independent cohort of renal transplant recipients
    Boughton, Oliver
    Borgulya, Gabor
    Cecconi, Maurizio
    Fredericks, Salim
    Moreton-Clack, Michelle
    MacPhee, Iain A. M.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (03) : 425 - 431
  • [47] Effects of Wuzhi Capsules on Blood Concentration of Tacrolimus in Renal Transplant Recipients
    Yan, Lin
    Yang, Zhi-Qiang
    Shi, Yun-Ying
    Ren, Ling
    Yang, Cui-Li
    Wan, Zheng-Li
    Bai, Yang-Juan
    Luo, Li-Mei
    Wang, Lan-Lan
    Li, Yi
    ANNALS OF TRANSPLANTATION, 2019, 24 : 594 - 604
  • [48] CONCENTRATION CONTROLLED MYCOPHENOLATE DOSING IN PEDIATRIC RENAL TRANSPLANTATION
    Mohapatra, Anjali
    Basu, Gopal
    Annapandian, M. V.
    Mathew, Binu S.
    David, Vinoi G.
    Varughese, Santosh
    Jacob, Chakko K.
    John, George T.
    Veeraswamy, Tamilarasi
    PEDIATRIC TRANSPLANTATION, 2011, 15 : 131 - 132
  • [49] Open-Label Study of Planned Transition from Tacrolimus to Sirolimus vs Continued Tacrolimus in Renal Allograft Recipients: Demographics and Interim Safety Results.
    Tedesco-Silva, H.
    Peddi, R.
    Russ, G.
    Marder, B.
    Hahn, C.
    Li, H.
    Flynn, A.
    Schulman, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 337 - 337
  • [50] Interim Results from an Open-Label Study of Planned Transition from Tacrolimus to Sirolimus vs Continued Tacrolimus in Renal Allograft Recipients: Cardiovascular Safety
    Tedesco-Silva, H.
    Peddi, V. R.
    Sanchez-Fructoso, A.
    Russ, G.
    Marder, B.
    Hahn, C.
    Li, H.
    Flynn, A.
    Schulman, S.
    TRANSPLANTATION, 2012, 94 (10) : 142 - 142
12345